原发性甲状旁腺功能亢进症患者术后糖尿病前期者的胰岛素抵抗改善
本研究观察2016至2021年间接受甲状旁腺切除术的原发性甲状旁腺功能亢进症患者231例,评估术前糖代谢异常严重程度与术后12个月胰岛素抵抗变化的关系。术前糖尿病前期75例(32%),胰岛素抵抗108例(47%)。术后12个月,糖尿病前期患者稳态模型评估胰岛素抵抗值下降-0.69(P = .04),胰岛素抵抗患者下降-0.85(P < .001)。
要点
- 糖尿病前期患者术后12个月胰岛素抵抗值下降-0.69(P = .04),胰岛素抵抗者下降-0.85(P < .001)。
- 糖尿病前期患者中48/75(64%)胰岛素抵抗降低,其中15/48(31%)空腹血糖恢复正常。
- 术前糖尿病前期(1.82,1.03-3.21;P = .037)或术前稳态模型评估胰岛素抵抗>2.5(3.90,2.23-6.75;P < .001)为术后胰岛素抵抗降低的独立预测因素。
核心结论
- 甲状旁腺切除术更可能降低原发性甲状旁腺功能亢进症合并糖尿病前期或术前稳态模型评估胰岛素抵抗值较高患者的胰岛素抵抗。
- 这些数据支持在甲状旁腺切除术的国际工作组标准之外使用术前糖尿病前期标准,以更好地选择手术患者。
研究设计与样本
- 观察性研究,纳入2016年至2021年间接受甲状旁腺切除术的患者231例。
- 糖尿病前期定义为空腹血糖≥1.00 g/L(美国糖尿病协会标准),胰岛素抵抗定义为稳态模型评估胰岛素抵抗>2.5。
主要发现
- 术前糖尿病前期患者75例(32%),胰岛素抵抗患者108例(47%)。
- 术后12个月,糖尿病前期患者稳态模型评估胰岛素抵抗值显著下降-0.69(P = .04),胰岛素抵抗患者下降-0.85(P < .001)。
- 糖尿病前期患者中48/75(64%)胰岛素抵抗降低,其中15/48(31%)空腹血糖恢复正常。
- 多因素分析显示,术前糖尿病前期(1.82,1.03-3.21;P = .037)或术前稳态模型评估胰岛素抵抗>2.5(3.90,2.23-6.75;P < .001)是术前至术后12个月胰岛素抵抗降低的独立预测因素。
关键数值与推荐
- 糖尿病前期定义为空腹血糖≥1.00 g/L(美国糖尿病协会标准)。
- 胰岛素抵抗定义为稳态模型评估胰岛素抵抗>2.5。
临床怎么用
- 作者认为,这些数据支持在甲状旁腺切除术的国际工作组标准之外使用术前糖尿病前期标准,以更好地选择手术患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The objective of this study was to evaluate the evolution of insulin resistance at 12 months after parathyroidectomy for primary hyperparathyroidism according to the preoperative severity of glucose metabolism abnormalities. METHODS: Observational study of patients who underwent parathyroidectomy between 2016 and 2021. Prediabetes and insulin resistance were defined as fasting glucose ≥1.00 g/L (American Diabetes Association) and homeostatic model assessment of insulin resistance >2.5, respectively. RESULTS: A total of 231 patients were included. Preoperatively, 75 patients (32%) had prediabetes, and 108 patients (47%) had insulin resistance. At 12 months postoperative, homeostatic model assessment of insulin resistance values significantly decreased in patients with prediabetes (-0.69; P = .04) and in patients with insulin resistance (-0.85; P < .001). In patients with prediabetes, 48/75 (64%) decreased their insulin resistance, including 15/48 (31%) with normalization of fasting glucose. In multivariate analysis, preoperative prediabetes (1.82, 1.03-3.21; P = .037) or preoperative homeostatic model assessment of insulin resistance >2.5 (3.90, 2.23-6.75; P < .001) remained independent predictors for insulin resistance reduction observed between preoperative and 12 months postoperative. CONCLUSION: Parathyroidectomy is more likely to reduce insulin resistance in patients with primary hyperparathyroidism and prediabetes or in patients with higher preoperative homeostatic model assessment of insulin resistance values. These data support the use of the preoperative prediabetes criterion in addition to the international workshop criteria for parathyroidectomy to better select patients for surgery.
引用
- Nomine-Criqui C, Bihain F, Nguyen-Thi PL, et al. Patients with prediabetes improve insulin resistance after surgery for primary hyperparathyroidism. Surgery. 2023. PMID: 37981555. doi:10.1016/j.surg.2023.04.072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。